CreditRiskMonitor.com, Inc. (OTCMKTS:CRMZ) Short Interest Up 1,000.0% in November
by Scott Moore · The Cerbat GemCreditRiskMonitor.com, Inc. (OTCMKTS:CRMZ – Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,100 shares, an increase of 1,000.0% from the October 31st total of 100 shares. Based on an average daily trading volume, of 5,500 shares, the short-interest ratio is presently 0.2 days.
CreditRiskMonitor.com Stock Down 1.7 %
OTCMKTS CRMZ traded down $0.06 during trading on Wednesday, hitting $3.45. 7,827 shares of the stock traded hands, compared to its average volume of 5,553. CreditRiskMonitor.com has a 12-month low of $2.00 and a 12-month high of $3.60. The company has a market capitalization of $36.98 million, a P/E ratio of 29.25 and a beta of 0.08. The firm has a 50-day simple moving average of $2.60 and a 200-day simple moving average of $2.31.
CreditRiskMonitor.com Company Profile
CreditRiskMonitor.com, Inc engages in the provision of interactive business-to-business software-as-a-service (Saas) subscription products for corporate credit and procurement professionals in the United States. The company's products include CreditRiskMonitor product provides subscribers with unlimited usage and coverage of public and private companies, featuring multi-period spreads of financial reports and ratio analysis, credit risk scores, payment-behavior scores, trend reports, peer analysis, and credit limit recommendations, as well as up-to-date financial news screened specifically for materiality in credit evaluation; and SupplyChainMonitor, creates a risk management solution built specifically for procurement, supply chain, sourcing, and finance personnel involved in the supplier lifecycle, risk assessment, and ongoing risk monitoring.
See Also
- Five stocks we like better than CreditRiskMonitor.com
- What is a buyback in stocks? A comprehensive guide for investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is a Dividend King?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Low P/E Ratio and What Does it Tell Investors?
- 2 Generic Drug Stocks Ready to Surge in 2025